On June 8, 2023, EU Scientific Committee on Consumer Safety (SCCS) published preliminary opinions respectively on the use of Butylparaben (CAS No. 94-26-8) and Methylparaben (CAS No. 99-76-3) in cosmetics. The views are open for comments until August 21, 2023.

Endocrine disruptors (EDs) are chemical substances that can alter the functioning of the endocrine system and consequently produce adverse effects on human health. Regarding the management of EDs, Regulation (EC) No 1223/2009 (Cosmetics Regulation) does not contain specific provisions. Instead, substances identified as EDs, including Butylparaben and Methylparaben, are currently subject to the general safety assessment of SCCS. To ensure their safe use in cosmetics, the European Commission requested SCCS to conduct safety assessments on Butylparaben and Methylparaben.

Based on the assessments of all available information, including the potential endocrine effects, SCCS considers the use of Butylparaben and Methylparaben in cosmetics to be safe as shown below:

Source: ChemLinked

Reference Links

If you have any questions regarding chemical compliance in Australia, please feel free to contact us.

Email: customer@reach24h.com

Tel: +86-400-809-5809

News Source: ChemLinked

REACH24H Consulting Group launched ChemLinked in 2012 as a leading service provider of comprehensive regulatory information and compliance solutions, meeting the growing demand for clear and concise regulatory advice and market intelligence in Asia, especially China.

You can register for a membership to read the latest news limitlessly every day on ChemLinked.